Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 32.22B | 33.42B | 29.91B | 30.64B | 26.51B | 21.42B |
Gross Profit | 9.98B | 9.82B | 9.96B | 9.53B | 8.64B | 8.21B |
EBITDA | 2.01B | 3.01B | 2.71B | 2.66B | 2.39B | 2.28B |
Net Income | 819.20M | 888.73M | 733.71M | 660.79M | 755.39M | 670.98M |
Balance Sheet | ||||||
Total Assets | 22.05B | 22.13B | 21.83B | 21.81B | 20.22B | 19.44B |
Cash, Cash Equivalents and Short-Term Investments | 3.35B | 3.22B | 3.69B | 3.59B | 3.07B | 4.79B |
Total Debt | 1.85B | 1.56B | 2.01B | 2.03B | 2.04B | 2.24B |
Total Liabilities | 7.61B | 7.22B | 7.69B | 7.58B | 6.86B | 6.77B |
Stockholders Equity | 14.45B | 14.91B | 14.13B | 13.80B | 13.37B | 12.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 667.22M | 810.80M | 1.13B | -568.08M | 548.64M |
Operating Cash Flow | 0.00 | 2.02B | 2.28B | 2.26B | 1.06B | 1.70B |
Investing Cash Flow | 0.00 | -1.67B | -1.45B | -1.49B | -2.25B | -1.56B |
Financing Cash Flow | 0.00 | -858.37M | -980.63M | -290.59M | -530.67M | -444.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥13.75B | 15.60 | 1.55% | 11.75% | 20.89% | ||
63 Neutral | HK$30.47B | 8.37 | 5.37% | 5.31% | -3.09% | 4.51% | |
€473.54M | 8.51 | 7.82% | 3.74% | ― | ― | ||
78 Outperform | ¥52.43B | 4.96 | 3.07% | -2.06% | -10.54% | ||
72 Outperform | ¥16.60B | 18.26 | 2.90% | 3.55% | -21.67% | ||
71 Outperform | ¥17.26B | 8.49 | 2.22% | 0.59% | ― | ||
64 Neutral | ¥35.30B | 10.77 | 2.02% | 0.03% | ― |